Cadre Holdings posted strong Q4 results, but slowing growth, valuation concerns, and tariff risks cloud the outlook. Learn ...

I delivered a talk at the 4th annual Law and Antisemitism conference held at the UCLA School of Law. At a time when the Trump ...

Revolution Medicines is a clinical-stage pharma company with a market cap of ~6 billion. Click here to find out why RVMD ...